According to the findings, CCNK immunoreactivity was considerably greater in tumor tissues than in nearby tissues for each of the three endometrial cancer subtypes that was studied: non-endometrioid adenocarcinoma (nEAC), EC, and endometrial adenocarcinoma (EAC). The gene discussed is CCNK; the disease is endometrium adenocarcinoma.